Vertex Pharmaceuticals (VRTX) Superinvestor holders
30 of the superinvestors we track hold Vertex Pharmaceuticals (VRTX) in their latest 13F filings, $7.1B in total.
Summary
The largest holder is Aziz Hamzaogullari (Loomis Sayles & Co), with $1.9B, 2.4% of the portfolio.
In their latest quarter: 2 opened a new position, 9 added, 17 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Aziz Hamzaogullari Loomis Sayles & Co |
Trimmed | 3,920,953 | $1.9B | 2.4% | Q2 2026 |
| Jennison Associates | Added | 2,998,530 | $1.5B | 0.9% | Q2 2026 |
| Hersh Cohen ClearBridge Investments |
Trimmed | 2,342,915 | $1.2B | 1.0% | Q2 2026 |
| WCM Investment Management | Added | 1,152,094 | $576M | 1.0% | Q2 2026 |
| Arrowstreet Capital | Added | 738,378 | $367M | 0.2% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 616,170 | $305M | 0.1% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 543,897 | $270M | 0.2% | Q2 2026 |
| Alan Breed Edgewood Management |
Trimmed | 531,003 | $264M | 2.7% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 320,008 | $159M | 0.2% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Trimmed | 285,000 | $142M | 0.1% | Q2 2026 |
| Baillie Gifford Baillie Gifford & Co |
Trimmed | 266,055 | $139M | 0.1% | Q3 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 210,483 | $105M | 0.2% | Q2 2026 |
| Man Group Man Group plc |
Trimmed | 139,233 | $69M | 0.1% | Q2 2026 |
| Acadian Acadian Asset Management |
Trimmed | 33,185 | $17M | 0.0% | Q3 2026 |
| Ken Fisher Fisher Investments |
Added | 28,676 | $15M | 0.0% | Q3 2026 |
| Paul Tudor Jones Tudor Investment Corp |
New position | 30,176 | $15M | 0.1% | Q2 2026 |
| Tweedy, Browne Tweedy, Browne Company |
Trimmed | 26,013 | $14M | 1.1% | Q3 2026 |
| Joel Greenblatt Gotham Asset Management |
Trimmed | 18,986 | $9M | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
Added | 17,622 | $9M | 0.1% | Q2 2026 |
| Brandon Haley Holocene Advisors |
Trimmed | 12,384 | $6M | 0.0% | Q2 2026 |
| Ray Dalio Bridgewater Associates |
Trimmed | 10,865 | $5M | 0.0% | Q2 2026 |
| Fayez Sarofim Fayez Sarofim & Co |
Held | 10,000 | $5M | 0.0% | Q2 2026 |
| Ron Baron Baron Capital (BAMCO) |
Trimmed | 6,000 | $3M | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 3,105 | $2M | 0.0% | Q2 2026 |
| Alger Fred Alger Management |
Added | 2,972 | $1M | 0.0% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
New position | 2,625 | $1M | 0.0% | Q2 2026 |
| First Manhattan First Manhattan Co |
Held | 1,560 | $774,899 | 0.0% | Q2 2026 |
| Harding Loevner | Trimmed | 1,163 | $577,661 | 0.0% | Q2 2026 |
| Fred DiSanto Ancora Holdings |
Added | 1,127 | $559,981 | 0.0% | Q2 2026 |
| Ken Tropin Graham Capital Management |
Trimmed | 685 | $340,260 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 31 |
| Q1 2026 | 30 |
| Q4 2025 | 29 |
| Q3 2025 | 30 |
| Q2 2025 | 29 |
| Q1 2025 | 27 |
| Q4 2024 | 34 |
| Q3 2024 | 28 |
Questions about Vertex Pharmaceuticals
Which superinvestors own Vertex Pharmaceuticals?
30 of the superinvestors we track hold Vertex Pharmaceuticals (VRTX) in their latest 13F filings, $7.1B in total. Aziz Hamzaogullari, Jennison Associates, Hersh Cohen, WCM Investment Management, Arrowstreet Capital, Cliff Asness.
Who is the largest superinvestor holder of VRTX?
The largest holder is Aziz Hamzaogullari (Loomis Sayles & Co), with $1.9B, 2.4% of the portfolio.
From Vertex Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.